Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Appointments topic

No spam. Unsubscribe anytime.

Appointee Clayton Steele outlines environmental background to Senate committee

Senate Health and Welfare Committee · January 26, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Clayton Steele, nominee for reappointment to the Board of Environmental Quality, told the Senate Health and Welfare Committee he brings about 25 years of environmental experience — including work at DEQ and Clearwater Paper — and said the Perpetua contested case was a major recent board matter.

Clayton Steele, the gubernatorial appointee to the Board of Environmental Quality, told the Senate Health and Welfare Committee he has worked in environmental fields for roughly 25 years and has served on the board for a couple of years. "My name is Clayton Steele. I live in Lewis And Idaho," Steele said when asked to introduce himself for the record. He said about half his career was at the Department of Environmental Quality in Lewiston and the other half in private industry at Clearwater Paper.

Steele described his board experience as largely focused on rulemaking and air-quality issues and noted he has participated in reviewing and approving rules several times. When asked what the boardhad faced recently, Steele cited a lengthy contested-case matter related to Perpetua, saying the board reviewed more than 100 documents and ultimately took the hearing officer's recommendation unanimously. "It was fairly complex," Steele said, describing the records review and the board's decision. He told senators he has not encountered a conflict of interest stemming from his prior employment with Clearwater Paper.

The committee chair said the formal vote on Steele's reappointment will take place at the next committee meeting (tomorrow). No vote occurred during this hearing.